Paper Details

  1. Home
  2. Paper Details

Pharmacotherapy Considerations in CKD Patients With COVID-19, A Narrative Review.

Author: Dashti-KhavidakiSimin, KhaliliHossein, NourianAnahid

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
ReviewAn article that critically examines existing research on a particular topic and summarizes the current state of knowledge in the field.

Overview

This review provides pharmacotherapy considerations for treating coronavirus disease 2019 (COVID-19) in patients with chronic kidney disease (CKD). The review discusses the selection and modification of COVID-19 treatments, drug interactions, nephrotoxicity of COVID-19 drugs, and potential risks and benefits of routine CKD medications during the pandemic.
Paper Details　
Original Abstract of the Article :
Treatment of coronavirus disease 2019 (COVID-19) among patients with CKD requires special pharmacotherapy considerations that are reviewed here. Literature review was done for several pharmacotherapy aspects in CKD patients including selection and modification of COVID-19 treatment, drug interaction...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://pubmed.ncbi.nlm.nih.gov/32655019

データ提供：米国国立医学図書館（NLM）

Pharmacotherapy Considerations in CKD Patients with COVID-19: A Narrative Review

The COVID-19 pandemic has created a complex [landscape for pharmacotherapy] in patients with chronic kidney disease (CKD). This narrative review addresses the specific [pharmacotherapy considerations] for managing COVID-19 in CKD patients. The authors discuss [drug selection, dose modification, drug interactions, and the potential nephrotoxicity of COVID-19 medications].

Navigating the Challenges of COVID-19 Treatment in CKD

This review highlights the need for a [tailored approach to pharmacotherapy] in CKD patients with COVID-19. The authors emphasize the importance of [considering the unique pharmacokinetic and pharmacodynamic characteristics of drugs] in the context of CKD.

Key Considerations for CKD Patients with COVID-19

CKD patients with COVID-19 should be [aware of the potential for drug interactions and nephrotoxicity]. They should [communicate openly with their healthcare provider] about their medications and any concerns they may have.

Dr.Camel's Conclusion

This review, like a seasoned desert guide, navigates the complexities of pharmacotherapy for CKD patients with COVID-19. The authors provide valuable insights and recommendations for managing these challenging situations. The guidance offered in this review can help improve patient outcomes and ensure safer and more effective treatment.

Date :
  1. Date Completed 2020-07-24
  2. Date Revised 2022-12-07
Further Info :

Pubmed ID

32655019

DOI: Digital Object Identifier

5775/1183

Related Literature

Article Analysis
・Side Effects of cinacalcet
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.